IDEAYA Biosciences, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · South San Francisco, CA
IDYA chart
What traders are saying about $IDYA
Latest postsIDEAYA Biosciences, Inc. news
- Mizuho cuts Ideaya Biosciences stock price target on dilution
Investing.com ·
- IDEAYA Biosciences (IDYA) Reports Earnings And Shelf Filing, Is The Stock Cheap?
Simply Wall St ·
- IDEAYA Biosciences (IDYA) Institutional Ownership 2026
MarketBeat ·
- Citigroup maintains IDEAYA Biosciences at Buy, raises price target to $66 from $65
TradingView ·
- How Investors Are Reacting To IDEAYA Biosciences (IDYA) Earnings And Drug Trial Updates
Simply Wall St ·
- IDEAYA Biosciences, Inc. (IDYA) Seasonal returns chart - Yahoo Finance
Yahoo Finance Singapore ·
- RBC Capital maintains IDEAYA Biosciences at Outperform, lowers price target to $45 from $48
TradingView ·
- Truist Securities maintains IDEAYA Biosciences at Buy, lowers price target to $57 from $59
TradingView ·
- Guggenheim maintains IDEAYA Biosciences at Buy, lowers price target to $52 from $57
TradingView ·
- Wedbush maintains IDEAYA Biosciences at Outperform, raises price target to $63 from $60
TradingView ·
- IDEAYA Biosciences announces participation in k...
Pluang ·
- IDEAYA Biosciences to Participate in Upcoming November 2026 Investor Relations Events
Yahoo Finance ·
IDEAYA Biosciences, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $218.7M | $7.0M | $23.4M | $50.9M |
| Net income | -$113.7M | -$274.5M | -$113.0M | -$58.7M |
| Diluted EPS | $-1.28 | $-3.36 | $-1.96 | $-1.42 |
| Total assets (year end) | $1.11B | $1.12B | $649.3M | $388.0M |
| Cash and equivalents (year end) | $112.8M | $84.4M | $157.0M | $68.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About IDEAYA Biosciences, Inc.
- Ticker
- IDYA (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1676725
Frequently asked questions
What exchange is IDEAYA Biosciences, Inc. listed on?
IDEAYA Biosciences, Inc. trades on the Nasdaq under the ticker symbol IDYA.
What industry is IDEAYA Biosciences, Inc. in?
IDEAYA Biosciences, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is IDEAYA Biosciences, Inc. headquartered?
IDEAYA Biosciences, Inc.'s business address on file with the SEC is in South San Francisco, CA.
When does IDEAYA Biosciences, Inc.'s fiscal year end?
IDEAYA Biosciences, Inc.'s fiscal year ends on December 31.
How much revenue did IDEAYA Biosciences, Inc. report?
IDEAYA Biosciences, Inc. reported $218.7M in revenue for calendar year 2025, according to its SEC filings.